Literature DB >> 32902682

Synbiotic VSL#3 and yacon-based product modulate the intestinal microbiota and prevent the development of pre-neoplastic lesions in a colorectal carcinogenesis model.

Bruna Cristina Dos Santos Cruz1, Vinícius da Silva Duarte2, Alessio Giacomini2, Viviana Corich2, Sérgio Oliveira de Paula3, Lilian da Silva Fialho4, Valéria Monteze Guimarães4, Célia Lúcia de Luces Fortes Ferreira5, Maria do Carmo Gouveia Peluzio6.   

Abstract

Colorectal cancer is a public health problem, with dysbiosis being one of the risk factors due to its role in intestinal inflammation. Probiotics and synbiotics have been used in order to restore the microbiota balance and to prevent colorectal carcinogenesis. We aimed to investigate the effects of the probiotic VSL#3® alone or in combination with a yacon-based prebiotic concentrate on the microbiota modulation and its influence on colorectal carcinogenesis in an animal model. C57BL/6J mice were divided into three groups: control (control diet), probiotic (control diet + VSL#3®), and synbiotic (yacon diet + VSL#3®). The diets were provided for 13 weeks and, from the third one, all animals were subjected to induction of colorectal cancer precursor lesions. Stool samples were collected to evaluate organic acids, feces pH, β-glucuronidase activity, and microbiota composition. The colon was used to count pre-neoplastic lesions and to determine the cytokines. The microbiota composition was influenced by the use of probiotic and synbiotic. Modifications were also observed in the abundance of bacterial genera with respect to the control group, which confirms the interference of carcinogenesis in the microbiota. Pre-neoplastic lesions were reduced by the use of the synbiotic, but not with the probiotic. The protection provided by the synbiotic can be attributed to the modulation of the intestinal inflammatory response, to the inhibition of a pro-carcinogenic enzyme, and to the production of organic acids. The modulation of the composition and activity of the microbiota contributed to beneficial changes in the intestinal microenvironment, which led to a reduction in carcinogenesis. KEY POINTS: • Synbiotic reduces the incidence of colorectal cancer precursor lesions. • Synbiotic modulates the composition and activity of intestinal microbiota. • Synbiotic increases the abundance of butyrate-producing bacteria.

Entities:  

Keywords:  Colorectal cancer; Gut microbiota; Prebiotic; Probiotic; Synbiotic

Mesh:

Year:  2020        PMID: 32902682     DOI: 10.1007/s00253-020-10863-x

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  3 in total

1.  Effects of Probiotics at the Interface of Metabolism and Immunity to Prevent Colorectal Cancer-Associated Gut Inflammation: A Systematic Network and Meta-Analysis With Molecular Docking Studies.

Authors:  Sinjini Patra; Nilanjan Sahu; Shivam Saxena; Biswaranjan Pradhan; Saroj Kumar Nayak; Anasuya Roychowdhury
Journal:  Front Microbiol       Date:  2022-05-27       Impact factor: 6.064

Review 2.  Efficacy of Probiotics-Based Interventions as Therapy for Inflammatory Bowel Disease: A Recent Update.

Authors:  Shanmugaprakasham Selvamani; Vijay Mehta; Hesham Ali El Enshasy; Suganthi Thevarajoo; Hala El Adawi; Ibrahim Zeini; Khoa Pham; Theodoros Varzakas; Bassam Abomoelak
Journal:  Saudi J Biol Sci       Date:  2022-03-01       Impact factor: 4.052

Review 3.  Preventing Colorectal Cancer through Prebiotics.

Authors:  Manijeh Mahdavi; Isabelle Laforest-Lapointe; Eric Massé
Journal:  Microorganisms       Date:  2021-06-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.